Similar Papers

Paper Title
Journal
Date
Author
Rates and results of germline genetic testing in patients with epithelial ovarian cancer at a tertiary care center.
Alexandra Samborski ... Meghan Underhill-Blazey
Journal of Clinical Oncology | VOL. 40
Alexandra Samborski, et. al.Alexandra Samborski ... Meghan Underhill-Blazey
01 Jun 2022
Taxane monotherapy regimens for the treatment of recurrent epithelial ovarian cancer.
Britta K Stordal ... Roshni Kalachand
Cochrane Database of Systematic Reviews | VOL. 7
Britta K Stordal, et. al.Britta K Stordal ... Roshni Kalachand
12 Jul 2022
Screening for ovarian cancer: imaging challenges and opportunities for improvement.
K B Mathieu ... R C Bast
Ultrasound in Obstetrics & Gynecology | VOL. 51
K B Mathieu, et. al.K B Mathieu ... R C Bast
01 Mar 2018
Disparities between Uptake of Germline BRCA1/2 Gene Tests and Implementation of Post-test Management Strategies in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients.
Young Min Hur ... Jaehee Mun
Journal of Korean medical science | VOL. 36
Young Min Hur, et. al.Young Min Hur ... Jaehee Mun
01 Jan 2020
View more papers

More From: Gynecologic Oncology

Paper Title
Journal
Date
Author
Molecular classification of endometrial cancers (EC) and association with relapse-free survival (RFS) and overall survival (OS) outcomes: Ancillary analysis of GOG-0258.
Aine Clements ... Angeles Alvarez Secord
Gynecologic oncology | VOL. 193
Aine Clements, et. al.Aine Clements ... Angeles Alvarez Secord
23 Jan 2025
Pembrolizumab in microsatellite instability-high/mismatch repair deficient (MSI-H/dMMR) and non-MSI-H/non-dMMR advanced endometrial cancer: Phase 2 KEYNOTE-158 study results.
David M O'Malley ... Michele Maio
Gynecologic oncology | VOL. 193
David M O'Malley, et. al.David M O'Malley ... Michele Maio
22 Jan 2025
Not all uterine carcinosarcomas are created equal: Survival outcomes according to molecular characterization of uterine carcinosarcoma.
Michael D Toboni ... Nathaniel Jones
Gynecologic oncology | VOL. 193
Michael D Toboni, et. al.Michael D Toboni ... Nathaniel Jones
20 Jan 2025
Cost-effectiveness of an additional hysterectomy after initially conservative treatment for cervical adenocarcinoma in situ.
M Schaafsma ... N.E Van Trommel
Gynecologic oncology | VOL. 193
M Schaafsma, et. al.M Schaafsma ... N.E Van Trommel
17 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.